# Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients

> **NCT01384994** · PHASE2 · UNKNOWN · sponsor: **PD Dr. med. Volker Heinemann** · enrollment: 111 (estimated)

## Conditions studied

- Colorectal Cancer
- KRAS Wildtype
- After Resection of Liver Metastases

## Interventions

- **DRUG:** Folic Acid
- **DRUG:** 5-FU
- **DRUG:** 5-FU
- **DRUG:** Oxaliplatin
- **DRUG:** Panitumumab
- **DRUG:** Panitumumab
- **DRUG:** Folic Acid
- **DRUG:** 5-FU
- **DRUG:** 5-FU
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT01384994
- **Lead sponsor:** PD Dr. med. Volker Heinemann
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2013-08
- **Final completion:** 2014-08
- **Target enrollment:** 111 (ESTIMATED)
- **Last updated:** 2012-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01384994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01384994, "Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01384994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*